Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashish Patel

Showing results (291-300 of 305) with videos related to

Pageof 31
Sort By:
Inflammatory Bowel Diseases|April 27, 2021
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative ColitisJeffrey S Hyams, Michael Brimacombe, Yael Haberman, et al.
Molecular Oncology|May 1, 2021
The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancerRahul Sreekumar, Hajir Al-Saihati, Muhammad Emaduddin, et al.
Environmental Toxicology and Pharmacology|December 29, 2023
A review on fluoride contamination in groundwater and human health implications and its remediation: A sustainable approachesPankaj Kumar, Manoj Kumar, Abdulwasa Bakr Barnawi, et al.
Clinical Cardiology|May 13, 2021
Contemporary use of guideline-based higher potency P2Y12 receptor inhibitor therapy in patients with moderate-to-high risk non-ST-segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross-sectional studyAshish Patel, Shaun G Goodman, Mary Tan, et al.
JAMA Network Open|November 16, 2022
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality TherapyAnthony M Magliocco, Jennifer Moughan, David T Miyamoto, et al.
Inflammatory Bowel Diseases|December 23, 2017
IBD Serology and Disease Outcomes in African Americans With Crohn's DiseaseMadeline Bertha, Arthi Vasantharoopan, Archana Kumar, et al.
Inflammatory Bowel Diseases|March 22, 2018
Enhanced Contribution of HLA in Pediatric Onset Ulcerative ColitisSuresh Venkateswaran, Jarod Prince, David J Cutler, et al.
The American Journal of Gastroenterology|April 20, 2022
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease: A Series of N-of-1 Diet TrialsHeather C Kaplan, Lisa Opipari-Arrigan, Jiabei Yang, et al.
Inflammatory Bowel Diseases|January 24, 2018
Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn DiseaseYael Haberman, Marina BenShoshan, Ayelet Di Segni, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2017
Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort studyJeffrey S Hyams, Sonia Davis, David R Mack, et al.
Pageof 31

Showing results (291-300 of 305) with videos related to

Sort By:
Pageof 31
Inflammatory Bowel Diseases|April 27, 2021
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative ColitisJeffrey S Hyams, Michael Brimacombe, Yael Haberman, et al.
Molecular Oncology|May 1, 2021
The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancerRahul Sreekumar, Hajir Al-Saihati, Muhammad Emaduddin, et al.
Environmental Toxicology and Pharmacology|December 29, 2023
A review on fluoride contamination in groundwater and human health implications and its remediation: A sustainable approachesPankaj Kumar, Manoj Kumar, Abdulwasa Bakr Barnawi, et al.
Clinical Cardiology|May 13, 2021
Contemporary use of guideline-based higher potency P2Y12 receptor inhibitor therapy in patients with moderate-to-high risk non-ST-segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross-sectional studyAshish Patel, Shaun G Goodman, Mary Tan, et al.
JAMA Network Open|November 16, 2022
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality TherapyAnthony M Magliocco, Jennifer Moughan, David T Miyamoto, et al.
Inflammatory Bowel Diseases|December 23, 2017
IBD Serology and Disease Outcomes in African Americans With Crohn's DiseaseMadeline Bertha, Arthi Vasantharoopan, Archana Kumar, et al.
Inflammatory Bowel Diseases|March 22, 2018
Enhanced Contribution of HLA in Pediatric Onset Ulcerative ColitisSuresh Venkateswaran, Jarod Prince, David J Cutler, et al.
The American Journal of Gastroenterology|April 20, 2022
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease: A Series of N-of-1 Diet TrialsHeather C Kaplan, Lisa Opipari-Arrigan, Jiabei Yang, et al.
Inflammatory Bowel Diseases|January 24, 2018
Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn DiseaseYael Haberman, Marina BenShoshan, Ayelet Di Segni, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2017
Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort studyJeffrey S Hyams, Sonia Davis, David R Mack, et al.
Pageof 31